Patent · US Active

Substituted bicyclic HCV inhibitors

US8709999B2 · kind B2 · utility

2Cited by
4References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2010
Grant dateApr 29, 2014
Priority date—
Expiry dateNov 13, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.